loader
Please Wait
Applying Filters...

Find excipient solutions to address Testosterone Propionate formulation challenges (e.g. drug delivery, bioavailability, taste masking, controlled release, solubility, stability etc).

Menu
$ API Ref.Price (USD/KG) : 394Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Jai Radhe Sales

02 5Gangwal Healthcare

03 5Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

04 2DFE Pharma

05 1Ingredion Pharma Solutions

06 10Microlex e.U

07 4Pluviaendo

08 3Prachin Chemical

09 4Roquette

10 4Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 1Sigachi Industries

12 3Vasa Pharmachem

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : SALLYSO™

Applications : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Sallyso 0.5 to 3.0%

Grade : Oral

arrow

04

arrow
2024 ACI Convention
Not Confirmed

06

arrow
2024 ACI Convention
Not Confirmed

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-101

Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-101

Applications : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

11

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-102

Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-102

Applications : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow
blank

13

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-103

Excipient Details : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-103

Applications : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

14

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

16

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

18

arrow
2024 ACI Convention
Not Confirmed

22

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank